
5-Amino-1,3,4-thiadiazole-2-thiol | CAS:2349-67-9
5-Amino-1,3,4-thiadiazole-2-thiol
- 名称:2-氨基-5-巯基-1,3,4-噻二唑; 5-氨基-2-巯基-1,3,4-噻二唑 | 5-Amino-1,3,4-thiadiazole-2-thiol
- CAS号:2349-67-9
- 别名:2-Amino-5-mercapto-1,3,4-thiadiazole
- 分子式:C2H3N3S2
- 分子量:133.18
- EINESC号:219-078-4
产品描述
物理化学性质
熔点 | 231-236 ºC |
---|---|
水溶性 | 不溶 |
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R36/37/38 |
安全说明书 | S26;S36 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.C Wolfrom et al.European journal of clinical pharmacology, 39(4), 377-383 (1990-01-01)
High-performance liquid chromatography of methotrexate analogs containing terminal lysine or ornithine and their dansyl derivatives.A A Kumar et al.Analytical biochemistry, 128(1), 191-195 (1983-01-01)
Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates.T E Ellenberger et al.The Journal of biological chemistry, 264(27), 15960-15966 (1989-09-25)
Determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N10-methylpteroic acid in biological fluids by liquid chromatography with fluorimetric detection.J Salamoun et al.Journal of chromatography, 378(1), 173-181 (1986-05-28)
Interference of 4-amino-4-deoxy-N10-methylpteroic acid with the radioimmunoassay of methotrexate.J W Paxton Clinical chemistry, 25(3), 491-492 (1979-03-01)
Rapid high-pressure liquid chromatographic determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N(10)-methylpteroic acid in biological fluids.H Breithaupt et al.Analytical biochemistry, 121(1), 103-113 (1982-03-15)
Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography.B Nuernberg et al.Journal of chromatography, 487(2), 476-482 (1989-02-24)
A simple preparation of the methotrexate metabolites 7-hydroxymethotrexate and 4-deoxy-4-amino-N10-methylpteroic acid.D A Cairnes et al.Therapeutic drug monitoring, 5(3), 363-366 (1983-01-01)
Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction.Masanobu Uchiyama et al.Biomedical chromatography : BMC, 26(1), 76-80 (2011-03-26)
High-performance liquid chromatographic determination of methotrexate in plasma.H N Alkaysi et al.Therapeutic drug monitoring, 12(2), 191-194 (1990-03-01)
Mass spectrometry of permethylated folic acid analogs.R G Smith et al.Biomedical mass spectrometry, 8(4), 144-148 (1981-04-01)
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.B C Widemann et al.The Journal of pharmacology and experimental therapeutics, 294(3), 894-901 (2000-08-17)
Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate.S J Kopytek et al.Chemistry & biology, 7(5), 313-321 (2000-05-10)
High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethortrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluid.D A Cairnes et al.Journal of chromatography, 231(1), 103-110 (1982-08-13)
An investigation into the source of the deglutamated metabolites of methotrexate in patients treated with high dose infusions.M J Stewart et al.Annals of clinical biochemistry, 23 ( Pt 2), 210-215 (1986-03-01)
The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.Eva Klapkova et al.Clinical laboratory, 57(7-8), 599-606 (2011-09-06)
Carboxypeptidase G2 rescue after high-dose methotrexate.L M DeAngelis et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 14(7), 2145-2149 (1996-07-01)
Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.M J Ahern et al.Annals of the rheumatic diseases, 50(7), 477-480 (1991-07-01)
Commentary.Michael C Milone Clinical chemistry, 56(12), 1795-1796 (2010-12-02)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!